<!DOCTYPE html><!-- Last Published: Tue Jan 07 2025 15:55:23 GMT+0000 (Coordinated Universal Time) --><html data-wf-domain="www.cambrianbio.com" data-wf-page="65e8fe9201c0e422942549c2" data-wf-site="600be113c4111047016de64a" lang="en" data-wf-collection="65e8fe9201c0e42294254a47" data-wf-item-slug="q-a-with-juliette-han-phd-chief-operating-officer-cambrian-biopharma"><head><meta charset="utf-8"/><title>cambrian Bio</title><meta content="width=device-width, initial-scale=1" name="viewport"/><link href="https://cdn.prod.website-files.com/600be113c4111047016de64a/css/cambrian-dev.webflow.0733b0f40.min.css" rel="stylesheet" type="text/css"/><script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script><link href="https://i0.wp.com/www.kibs.co.ke/wp/wp-content/uploads/2023/10/kibs-logo-02.png?fit=120,85&amp;ssl=1" rel="shortcut icon" type="image/x-icon"/><link href="https://cdn.prod.website-files.com/600be113c4111047016de64a/600be12d2137ed834d86305c_webclip.png" rel="apple-touch-icon"/><script async="" src="https://www.googletagmanager.com/gtag/js?id=G-Y7NNGFHMFL"></script><script type="text/javascript">window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments);}gtag('js', new Date());gtag('config', 'G-Y7NNGFHMFL', {'anonymize_ip': false});</script><meta name="pinterest" content="nopin" />
<meta name="twitter:card" content="summary_large_image">

<!-- CUSTOM STYLE -->
<style>
html{-webkit-font-smoothing:antialiased;-moz-font-smoothing:antialiased;-o-font-smoothing:antialiased}
body{overscroll-behavior:none;-webkit-tap-highlight-color:transparent}
input,select,textarea{appearance:none;-moz-appearance:none;-webkit-appearance:none}
  
@media screen and (max-width:767px){
  .modal{display:block}
  .modal .c-660{height:-webkit-fill-available}
  .modal .abs-shadow-card{display:none}
  .modal h3{font-size:1.75em}
  }
</style>
<!-- END CUSTOM STYLE -->

<style>
.footer .s:first-child{background:linear-gradient(180deg, #0D141F 0%, #164067 100%)}
.footer .s:last-child{background-color:#164067}
.menu{background-image:linear-gradient(20.76deg, #335D2D -1.44%, #28557D 80.56%)}
</style></head><body><div class="no w-embed"><style>
a{color:inherit}
.notif-wrap ~ .nav{position:relative!important;transform:none!important}
.nav-wrap.with-notif{transform:none!important}
input:valid{border-color:#36c}
.w-form-done p{font-weight:500!important}
.w-form-fail{padding:1em;border-radius:10px;font-size:1em;text-align:center;margin-top:1em;font-weight:400;letter-spacing:-0.02em}
.row:first-child,.row-team:first-child,.pipeline .w-dyn-item:first-child .grid,.rt.preview p:first-child{margin-top:0}
.link-social:last-child{margin-right:0}
.tr{pointer-events:none}
.btn:not(.btn-blue):not(.btn-maroon):not(.btn-upload){background:linear-gradient(90deg, #109E5A 0%, #3366CC 100%)}
.abs svg{position:absolute;left:0;top:0;right:0;bottom:0;width:100%;height:auto}
.abs.abs-bg-bot svg{top:auto}
.abs.abs-footer svg,.c-404 svg{height:100%}
.s-404{max-height:-webkit-fill-available}
.cta p{display:inline-block;font-weight:500;line-height:1.4}
.cta:hover .cta-arrow,.cta:focus .cta-arrow,.link-block:hover .cta-arrow,.link-block:focus .cta-arrow{transform:translateX(.25em)}
.cta:hover .cta-arrow.cta-arrow-inverse,.cta:focus .cta-arrow.cta-arrow-inverse{transform:translateX(-.25em)}
.clamp{overflow:hidden;display:-webkit-box;-webkit-box-orient:vertical;-webkit-line-clamp:3}
.clamp.clamp2{-webkit-line-clamp:2}
.item::after{content:"";background:radial-gradient(circle at 50%,#d8a76e,#f8f0e5);display:block;position:absolute;bottom:0;width:100%;height:1px}
.link-block .cta{transition:opacity 500ms}
.link-block:hover .cta,.link-block:focus .cta,.link-external:hover ~ a .cta,.link-external:focus ~ a .cta{opacity:60%}
.rt blockquote + h6{color:#fff;position:relative;bottom:7em;margin-bottom:-1em}
.rt blockquote + h6 em{font-weight:300;color:#D8A76E;margin-left:1.4em}
.rt figure,.rt .w-embed{margin:3.75em 0}
.rt figure:last-child,.rt .w-embed:last-child{margin-bottom:0}
.rt figure, .rt .w-embed{border-radius:.938em;-webkit-mask-image:-webkit-radial-gradient(white, black)}
.rt figure.w-richtext-figure-type-image,.article img{border-radius:.625em}
.s-privacy .rt a{color:#b1c3e8}
.bg{transform:scale3d(1,1,1);transform-style:preserve-3d}
.link-qa:hover .bg,.link-qa:focus .bg,.link-external:hover ~ .link-qa .bg,.link-external:focus ~ .link-qa .bg{transform:scale3d(1.025,1.025,1)}
.link-qa:hover .btn,.link-qa:focus .btn{filter:brightness(120%);-webkit-filter:brightness(120%)}
.featured .w-dyn-list, .featured .w-dyn-items,.featured .w-dyn-item,.featured .link-qa{height:100%}
.w-file-upload-default,.w-file-upload-uploading{height:3.176470588235294em;display:block}
.w-file-upload-file-name{font-size:inherit}

@media screen and (max-width:479px){
.link-footer:not(:first-child){margin-right:0}
.rt blockquote + h6,.rt blockquote + h6 em{margin-left:0!important}
.rt blockquote + h6{bottom:6em!important;margin-bottom:-3em!important}
.rt blockquote + h6 em{display:block}
.link-qa img{transform:none!important}
.link-qa{color:#F8F0E5!important}
.s1-home,.s1-about,.s1-pipeline,.s1-science{max-height:none!important}
.s1.s1-team{max-height:-webkit-fill-available!important}
.link-contact .btn{width:100%;text-align:center}
.s1{max-height:-webkit-fill-available}
}
@media screen and (min-width:480px){.abs-qa{background-color:transparent!important}}
@media screen and (max-width:767px){
.rt figure,.rt .w-embed{margin:2.5em 0}
.link-team h3{font-size:1.5em}
.rt h2:first-child{margin-top:1.5em}
.card-modal{min-height:-webkit-fill-available}
}
@media screen and (min-width:768px) and (max-width:991px){.s1{max-height:-webkit-fill-available}}
@media screen and (max-width:991px){
.rt blockquote + h6{margin-left:60px;bottom:4.5em;margin-bottom:-1.5em}
.rt blockquote + h6 em{margin-left:1em}
.item .pc.pc-4{margin-top:.2em}
}
@media screen and (min-width:992px){
.s.s1:not(.s1-team){height:calc(100vh + 1vw)}
.s.s1.s1-about{height:calc(100vh + 5vw)}
.s.s1.s1-science{height:calc(100vh + 2vw)}
.row-team:nth-child(3) .grid{-ms-grid-columns:1fr 1fr 1fr 1fr;grid-template-columns:1fr 1fr 1fr 1fr}
.row-team:nth-child(3) h3{font-size:1.25em;font-weight:500}
.menu{background:none!important}
.grid-qa-2 .w-dyn-item:first-child{display:none}
}
@media screen and (min-width:992px) and (max-width:1180px){
.rt blockquote + h6{left:2.75em}
.rt blockquote{margin-left:-1.5em;margin-right:-1.5em}
.c1-contact{padding-top:30px}
.left-110{padding-left:0}
.right-110{padding-right:0}
.c2-contact .left-110{padding-left:3em}
.c2-contact .right-110{padding-right:3em}
.grid.grid-pipeline{font-size:1.2vw}
}
@media screen and (min-width:992px) and (max-width:1360px){body{font-size:14px}}
@media screen and (min-width:992px) and (max-width:1360px){.p-17.p-pipeline-phase.categ{font-size:16px}}
@media screen and (min-width:1792px){
.grid.grid-gap-143{grid-column-gap:8.9375em}
.left-110{padding-left:6.875em}
.right-110{padding-right:6.875em}
}
@media screen and (min-width:2200px){body{font-size:18px}}
</style></div><div class="tr" data-ix="tr"></div><div data-collapse="medium" data-animation="default" data-duration="800" data-easing="ease-out-expo" data-easing2="ease-out-expo" data-w-id="710a0016-3feb-10ed-f3e7-f258a52639cb" role="banner" class="s nav w-nav"><nav class="c"><div class="logo"><a href="../index.html" aria-label="home" class="w-inline-block"><div class="w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="7.1875em" height="1.25em" viewBox="0 0 115 20" fill="currentColor"><path d="M104.144 7.712a5.74 5.74 0 0 1 3.918-1.489 6.14 6.14 0 0 1 2.638.589c.823.389 1.543.956 2.107 1.657.836 1.029 1.28 2.327 1.28 4.518v6.226h-2.641v-6.377c0-1.626-.304-2.382-.776-2.951a3.44 3.44 0 0 0-1.199-.91c-.464-.213-.971-.322-1.484-.32a4.92 4.92 0 0 0-2.083.495 4.79 4.79 0 0 0-1.657 1.327v8.736h-2.641V6.496h2.557l-.019 1.216zM36.15 6.559V7.78c1.04-.948 2.409-1.48 3.833-1.489.881-.005 1.752.182 2.549.547s1.501.898 2.06 1.562a6.54 6.54 0 0 1 2.246-1.577c.855-.364 1.781-.545 2.714-.532a6.04 6.04 0 0 1 2.569.552 5.89 5.89 0 0 1 2.068 1.584c.804.975 1.192 2.218 1.192 4.359v6.49h-2.637V12.38c0-1.303-.276-2.004-.748-2.546a3.2 3.2 0 0 0-1.098-.815c-.423-.191-.882-.291-1.347-.291a5.49 5.49 0 0 0-2.187.497 5.36 5.36 0 0 0-1.787 1.325 10.14 10.14 0 0 1 .234 2.236v6.49h-2.637V12.38c0-1.303-.28-2.004-.753-2.546-.315-.35-.703-.63-1.139-.821s-.908-.288-1.386-.286c-.709.03-1.403.209-2.035.523s-1.188.757-1.63 1.299v8.727H33.59V6.559h2.557zM9.817.001c1.33-.014 2.648.238 3.874.741a9.71 9.71 0 0 1 3.25 2.183L15.754 4.1a.95.95 0 0 1-1.225.082C13.187 3.147 11.528 2.58 9.817 2.57c-3.974 0-7.054 3.088-7.054 7.169 0 4.277 3.165 7.174 7.302 7.174 1.891-.034 3.697-.774 5.044-2.068a.95.95 0 0 1 1.257 0l1.253 1.116c-.915 1.092-2.067 1.974-3.373 2.582a10.03 10.03 0 0 1-4.181.934C4.277 19.481 0 15.341 0 9.739 0 4.277 4.207.001 9.817.001zm69.715 7.87a.85.85 0 0 1-.069.335.87.87 0 0 1-.196.283c-.084.081-.183.145-.293.188s-.227.065-.345.064a4.62 4.62 0 0 0-2.202.582 4.47 4.47 0 0 0-1.631 1.554v8.335h-2.641V6.496h2.557v1.512a4.9 4.9 0 0 1 1.774-1.254 5.02 5.02 0 0 1 2.158-.376c.297-.002.594.016.888.055v1.439zM82.421.269a1.79 1.79 0 0 1 .672.129 1.75 1.75 0 0 1 .569.37 1.7 1.7 0 0 1 .38.555 1.66 1.66 0 0 1 .132.654 1.64 1.64 0 0 1-.137.646 1.68 1.68 0 0 1-.382.545 1.73 1.73 0 0 1-.568.359 1.76 1.76 0 0 1-.666.117 1.73 1.73 0 0 1-.663-.12 1.69 1.69 0 0 1-.562-.363 1.66 1.66 0 0 1-.372-.548 1.61 1.61 0 0 1-.123-.646 1.64 1.64 0 0 1 .124-.648c.085-.206.211-.393.371-.552a1.7 1.7 0 0 1 .561-.369 1.76 1.76 0 0 1 .664-.13zm-1.304 6.226h2.641v12.717h-2.641V6.496zm-52.512.001v8.736a4.49 4.49 0 0 1-1.57 1.322c-.621.316-1.31.487-2.011.5-.569.01-1.134-.092-1.663-.298a4.27 4.27 0 0 1-1.412-.905c-.404-.391-.724-.856-.94-1.369s-.325-1.063-.319-1.618c0-2.218 1.58-4.195 3.702-4.195a3.19 3.19 0 0 1 1.575.355.96.96 0 0 0 .584.11c.202-.026.389-.116.534-.255l1.402-1.366a6.24 6.24 0 0 0-3.885-1.284c-1.12-.013-2.222.267-3.193.811-1.031.602-1.883 1.456-2.471 2.476s-.894 2.174-.885 3.344c-.013 1.164.287 2.311.872 3.327a6.74 6.74 0 0 0 2.457 2.462 6.82 6.82 0 0 0 3.272.838 6.09 6.09 0 0 0 4.03-1.435v1.166h2.552V6.496h-2.632zm67.461-.119V15.1c-.412.553-.949 1.005-1.571 1.321a4.63 4.63 0 0 1-2.01.501 4.36 4.36 0 0 1-1.663-.3 4.27 4.27 0 0 1-1.412-.906 4.15 4.15 0 0 1-.939-1.37 4.06 4.06 0 0 1-.319-1.618c0-2.218 1.585-4.195 3.707-4.195.546-.017 1.088.106 1.571.355a.96.96 0 0 0 .584.11c.202-.026.389-.116.534-.255l1.402-1.366c-1.005-.74-2.211-1.178-3.469-1.259a6.6 6.6 0 0 0-3.609.803 6.79 6.79 0 0 0-2.474 2.473c-.589 1.021-.895 2.173-.887 3.344a6.51 6.51 0 0 0 .872 3.329c.585 1.016 1.434 1.864 2.461 2.46a6.81 6.81 0 0 0 3.272.838c1.477.022 2.911-.489 4.025-1.435v1.166h2.552V6.377h-2.627zm-28.978.656c-.971-.544-2.073-.824-3.193-.811a6.15 6.15 0 0 0-3.922 1.366l1.309 1.339a.94.94 0 0 0 .53.274.96.96 0 0 0 .592-.096 3.34 3.34 0 0 1 1.543-.373c2.211 0 3.861 1.904 3.861 4.099.006.554-.103 1.104-.319 1.616s-.535.978-.938 1.369a4.27 4.27 0 0 1-1.411.905 4.36 4.36 0 0 1-1.661.3c-.702-.012-1.391-.182-2.014-.498a4.49 4.49 0 0 1-1.572-1.323V0h-2.636v19.212h2.58v-1.166c1.113.947 2.547 1.458 4.025 1.435a6.83 6.83 0 0 0 3.272-.838c1.027-.596 1.875-1.445 2.46-2.461a6.52 6.52 0 0 0 .873-3.328c.007-1.173-.301-2.328-.894-3.349a6.81 6.81 0 0 0-2.486-2.472z"/></svg></div></a></div><nav role="navigation" id="menu" class="menu w-nav-menu"><div class="menu-inner"><div class="no-tb"></div><div class="center"><a href="../about.html" tabindex="0" class="navlink">About</a><a href="../science.html" tabindex="0" class="navlink">Science</a><a href="../pipeline.html" class="navlink">Pipeline</a><a href="../team.html" class="navlink">Team</a><a href="../careers-page.html" class="navlink">Careers</a><a href="../news-and-publications.html" class="navlink">News &amp; Publications</a><a href="../blogs.html" class="navlink">Blog</a></div><div class="right"><a role="button" href="../contact.html" target="_blank" class="btn btn-sm w-button">Contact</a></div></div></nav><div class="menu-btn w-nav-button"><div class="menu-bar menu-bar-top"></div><div class="menu-bar menu-bar-mid"></div><div class="menu-bar menu-bar-bot"></div></div></nav></div><main class="main"><section class="s s1-post s1-qa"><div class="abs abs-bg-bot larger-tb w-embed"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="1793" height="334" viewBox="0 0 1793 334" fill="none"><mask id="dividerpost1" mask-type="alpha" maskUnits="userSpaceOnUse" x="0" y="0" width="1793" height="334"><path fill="#c4c4c4" d="M0 0h1793v334H0z"/></mask><g mask="url(#dividerpost1)"><path d="M0 318h856.534a150 150 0 0 0 100.869-38.98l83.697-76.041c27.6-25.082 63.57-38.979 100.87-38.979H1792v178.519H0V318z" fill="#fff"/><mask id="dividerpost2" mask-type="alpha" maskUnits="userSpaceOnUse" x="0" y="68" width="1784" height="198"><path d="M0 69h1784v197H0V69z" fill="#c4c4c4"/></mask><g mask="url(#dividerpost2)"><path d="M1078.41 124.811h17c-34.04 0-66.86 12.632-92.09 35.445l-75.935 68.639a137.33 137.33 0 0 1-92.089 35.445h-16.997a137.33 137.33 0 0 0 92.089-35.445l75.932-68.639c25.24-22.813 58.06-35.445 92.09-35.445z" fill="url(#dividerpost3)"/><path fill-rule="evenodd" d="M985.859 159.793c25.361-22.897 58.351-35.575 92.551-35.575h761.15v1.369h-744.15c-33.87 0-66.52 12.553-91.63 35.222l-75.935 68.549c-25.362 22.897-58.346 35.576-92.549 35.576H193.123v-1.37h625.176a136.74 136.74 0 0 0 91.628-35.221l75.932-68.55zM837.885 263.54c32.935-.623 64.569-13.106 89.039-35.197l75.936-68.55c20.47-18.486 45.92-30.311 72.96-34.181-32.94.622-64.57 13.106-89.04 35.197l-75.932 68.549a138.08 138.08 0 0 1-72.963 34.182z" fill="url(#dividerpost4)"/><path d="M1036.25 96.906h17c-34.03 0-66.851 12.632-92.087 35.445l-75.932 68.639c-25.237 22.812-58.056 35.445-92.089 35.445h-16.997a137.33 137.33 0 0 0 92.088-35.445l75.932-68.639c25.237-22.813 58.055-35.445 92.085-35.445z" fill="url(#dividerpost5)"/><path fill-rule="evenodd" d="M943.705 132.038c25.363-22.994 58.345-35.726 92.545-35.726h761.16v1.375h-744.16a136.42 136.42 0 0 0-91.627 35.371l-75.932 68.838c-25.363 22.994-58.346 35.726-92.549 35.726H150.969v-1.375h625.176c33.862 0 66.518-12.606 91.628-35.371l75.932-68.838zM795.73 236.222c32.935-.625 64.57-13.161 89.04-35.346l75.932-68.838c20.477-18.564 45.918-30.44 72.968-34.326a136.42 136.42 0 0 0-89.044 35.346l-75.932 68.838c-20.477 18.564-45.921 30.44-72.964 34.326z" fill="url(#dividerpost6)"/><path d="M994.966 69.594h16.994a137.25 137.25 0 0 0-92.058 35.445l-75.905 68.639a137.25 137.25 0 0 1-92.055 35.445h-16.991a137.25 137.25 0 0 0 92.055-35.445l75.905-68.639c25.227-22.813 58.034-35.445 92.055-35.445z" fill="url(#dividerpost7)"/><path fill-rule="evenodd" d="M902.45 104.575A138.04 138.04 0 0 1 994.966 69h760.884v1.37h-743.89c-33.853 0-66.497 12.553-91.598 35.222l-75.905 68.549c-25.353 22.897-58.325 35.576-92.515 35.576H110v-1.37h624.951c33.85 0 66.493-12.552 91.595-35.221l75.904-68.55zM754.529 208.322a136.66 136.66 0 0 0 89.008-35.197l75.904-68.55c20.47-18.486 45.905-30.311 72.938-34.181-32.923.622-64.547 13.106-89.008 35.197l-75.905 68.549c-20.469 18.486-45.904 30.312-72.937 34.182z" fill="url(#dividerpost8)"/></g></g><defs><linearGradient id="dividerpost3" x1="816.51" y1="285.453" x2="1104.88" y2="124.592" xlink:href="#dividerpost9"><stop stop-color="#36c"/><stop offset="1" stop-color="#d8a76e"/></linearGradient><linearGradient id="dividerpost4" x1="1504.21" y1="78.148" x2="241.018" y2="265.051" xlink:href="#dividerpost9"><stop stop-color="#d8a76e" stop-opacity="0"/><stop offset=".322" stop-color="#d8a76e"/><stop offset=".535" stop-color="#36c"/><stop offset="1" stop-color="#36c" stop-opacity="0"/></linearGradient><linearGradient id="dividerpost5" x1="774.356" y1="257.547" x2="1062.73" y2="96.687" xlink:href="#dividerpost9"><stop stop-color="#36c"/><stop offset="1" stop-color="#d8a76e"/></linearGradient><linearGradient id="dividerpost6" x1="1462.06" y1="50.048" x2="198.637" y2="236.199" xlink:href="#dividerpost9"><stop stop-color="#d8a76e" stop-opacity="0"/><stop offset=".322" stop-color="#d8a76e"/><stop offset=".535" stop-color="#36c"/><stop offset="1" stop-color="#36c" stop-opacity="0"/></linearGradient><linearGradient id="dividerpost7" x1="733.162" y1="230.236" x2="1021.48" y2="69.464" xlink:href="#dividerpost9"><stop stop-color="#36c"/><stop offset="1" stop-color="#d8a76e"/></linearGradient><linearGradient id="dividerpost8" x1="1420.61" y1="22.93" x2="157.858" y2="209.701" xlink:href="#dividerpost9"><stop stop-color="#d8a76e" stop-opacity="0"/><stop offset=".322" stop-color="#d8a76e"/><stop offset=".535" stop-color="#36c"/><stop offset="1" stop-color="#36c" stop-opacity="0"/></linearGradient><linearGradient id="dividerpost9" gradientUnits="userSpaceOnUse"/></defs></svg></div><div class="c c-890"><a href="javascript:history.back();" class="cta w-inline-block"><div class="cta-arrow cta-arrow-inverse w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="0.5em" height="0.875em" viewBox="0 0 8 14" fill="none"><path d="M7 13L1 7L7 1" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round"/></svg></div><p class="p-17">Back</p></a></div></section><section class="s s-120"><div class="c c-890 w-clearfix"><div class="share"><div class="pc pc-10 _0-tb w-embed"><a onclick="window.open(this.href, 'sharelink','width=580,height=680');return false;" class="sharelink" aria-label="share on twitter" href="http://twitter.com/share?url=https://www.cambrianbio.com/q-a/q-a-with-juliette-han-phd-chief-operating-officer-cambrian-biopharma&text=Q&amp;A with: Juliette Han, PhD, Chief Operating Officer, cambrian Biopharma&via=cambrianBio"><svg xmlns="http://www.w3.org/2000/svg" width="1.75em" height="1.375em" viewBox="0 0 28 22" fill="none"><path d="M24.646 5.408v.698c0 7.222-5.515 15.561-15.567 15.561a15.72 15.72 0 0 1-8.412-2.442c.419.035.873.07 1.291.07a11.08 11.08 0 0 0 6.806-2.338c-2.408-.035-4.433-1.64-5.096-3.803.349.07.663.105 1.047.105.489 0 .977-.07 1.431-.209-2.513-.488-4.398-2.687-4.398-5.338v-.07c.733.419 1.571.663 2.478.698a5.48 5.48 0 0 1-2.443-4.571c0-1.012.279-1.954.733-2.756a15.57 15.57 0 0 0 11.274 5.722c-.105-.384-.14-.837-.14-1.256 0-3.035 2.443-5.478 5.48-5.478a5.45 5.45 0 0 1 3.979 1.71c1.257-.244 2.408-.698 3.49-1.326-.419 1.291-1.291 2.338-2.408 3.035 1.117-.14 2.164-.419 3.141-.872-.698 1.116-1.606 2.093-2.688 2.861z" fill="#e2ecff"/></svg></a></div><div class="pc pc-20 pc-share w-embed"><a onclick="window.open(this.href, 'sharelink','width=580,height=540');return false;" class="sharelink" aria-label="share on linkedin" href="http://www.linkedin.com/shareArticle?mini=true&url=https://www.cambrianbio.com/q-a/q-a-with-juliette-han-phd-chief-operating-officer-cambrian-biopharma&title=Q&amp;A with: Juliette Han, PhD, Chief Operating Officer, cambrian Biopharma"><svg xmlns="http://www.w3.org/2000/svg" width="1.3125em" height="1.25em" viewBox="0 0 21 20" fill="#e2ecff"><path d="M20.584 19.993a79.33 79.33 0 0 0-3.804 0c-.274 0-.335-.061-.335-.335v-6.786c0-.517-.03-1.034-.183-1.521-.456-1.582-2.282-2.16-3.591-1.095-.7.548-.974 1.308-.974 2.221v6.39c0 .274-.03.548 0 .852.03.243-.091.304-.304.274H7.5c-.243 0-.304-.061-.304-.304l.03-5.782-.03-7.09c0-.274.061-.335.304-.335h3.895c.243 0 .304.061.304.304v1.552l.152-.152c1.187-1.734 2.86-2.221 4.838-1.917 2.282.365 3.743 1.947 4.108 4.382a11.08 11.08 0 0 1 .122 1.734v7.272c0 .243-.061.335-.335.335zM4.761 13.238v6.39c0 .274-.061.365-.335.365-1.278-.03-2.556 0-3.834 0-.243 0-.304-.061-.304-.304V6.787c0-.213.061-.304.304-.304h3.925c.274 0 .304.091.304.335l-.061 6.42zm.213-10.285C4.67 4.17 3.423 4.87 1.992 4.626.471 4.383-.381 2.892.167 1.431.532.518 1.414-.029 2.54.001c1.704-.03 2.83 1.339 2.434 2.952z"/></svg></a></div></div><article class="article"><h1 class="h1-h2">Q&amp;A with: Juliette Han, PhD, Chief Operating Officer, cambrian Biopharma</h1><div class="pc pc-30"><div class="flex"><div class="margin-right-4"><p class="regular">5</p></div><div class="margin-right-40"><p class="regular">min read</p></div><div class="margin-right-4"><p>01</p></div><div class="margin-right-4"><p>Jan</p></div><p>21</p></div></div><div class="pc pc-60 _30-ld"><div class="rt preview w-richtext"><p>Juliette Han is the Chief Operating Officer at cambrian Biopharma. She was previously the Chief of Staff at Two Sigma Private Investments Group. Prior to Two Sigma, Juliette was a Chief Operating Officer of People &amp; Human Resources Operations at the hedge fund Citadel, and is an alumna of McKinsey &amp; Co. Juliette holds a Ph.D. in Neuroscience from Harvard University <a href="../team.html#leadership">(learn more about Juliette)</a>.</p></div></div><div class="pc pc-60 _40-ld"><img alt="" loading="lazy" src="https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3.png" sizes="(max-width: 991px) 87vw, 79vw" srcset="https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3-p-500.png 500w, https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3-p-800.png 800w, https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3-p-1080.png 1080w, https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3-p-1600.png 1600w, https://cdn.prod.website-files.com/604c79c5c2649addebab824c/632e17eb52f65abb79c043c0_3.png 1780w" class="img"/></div><div class="rt w-richtext"><h2>What is cambrian’s basic strategy?</h2><p>We&#x27;re figuring out a way to make the drug discovery process more thoughtfully and flexibly resourced and programmatic, to increase its overall chance of success. The chance of success in drug R&amp;D is so slim that it often feels like a fishing expedition. Finding that one molecule, that one therapy that&#x27;s going to work without significant side effects is an incredibly difficult pursuit. But science and technology has progressed so much in the last 10 to 20 years that we believe it’s time to  take a new look at drug discovery and look for opportunities to make the process more successful, especially in early pre-clinical phases of development.</p><h2>Is cambrian a fund or a company?</h2><p>We are a company. Unlike funds, we have no restrictions around things like deadline to return all invested capital and performance tied to that deadline, which means that we can truly prioritize making great drugs as our primary lever, not investment timelines or returns. We’re driven by the mission of creating these new drugs, and that’s what we put first. As a company, we generate funding and we put that towards resourcing different types of therapies, which distributes the risk inherent in R&amp;D, and we can take the long-term view, deploying resources as needed to make the program successful. We have founders with equity in the company, and we have investors investing into cambrian as a whole, but they are not LPs.</p><p>I think that&#x27;s a huge advantage for our investor base because if you invest into a biotech that has one asset, that’s a huge risk. One bad readout and it&#x27;s done. By investing in cambrian, investors get the exposure in early-stage biotech they are looking for, while diversifying their bets. Our team of scientists turned drug developers perform the deep technical and business diligence required. Then we work very closely with our drug programs and have very defined milestones at every stage. If a program isn’t working out, we can quickly reassess and divert those resources elsewhere.</p><h2>What sets cambrian apart from other longevity companies?</h2><p>Longevity is a very broad term, and we like to think that we’re pioneering a new definition where we’re thinking about and understanding the biological mechanisms that change in the cell or body over time. We’re not trying to fight the end of life or be “immortal”—that&#x27;s what a lot of people perceive when they hear “longevity”. What we&#x27;re trying to answer is, how do we stay as healthy as possible? Why do we have to lose immunity? Why should we lose the way our organs function? Our goal is to really understand the mechanisms that go awry with age and how to make them preventable.</p><h2>How did you get interested in this field?</h2><p>In my training, including my PhD, I was interested in development in prenatal and early developmental systems and neuroscience. The theme was around what is the &quot;normal state,&quot; and then how do things become abnormal? For me, thematically, the prenatal and early human development field is similar to the way we approach longevity. In the long run, I believe that everything that happens in a human body is all correlated. That&#x27;s why when you feel stressed about money, jobs, or relationships, your body reacts holistically—your sleep patterns change, your endocrine system is out of function, your immune system goes down.</p><h2>How is cambrian working to better understand this interconnection?</h2><p>It will take a while for us to understand how everything is intricately related. In the R&amp;D world, this is not always the most positive thing, because you tend to focus on one mechanism and have to constantly worry about unforeseen side effects. We would ultimately like to understand how all of these mechanisms are interrelated. We go really deep into that scientifically and make multiple bets.</p><h2>How does cambrian support this effort?</h2><p>Our sweet spot is finding scientists with promising druggable targets that align with our mandate, and we provide the drug discovery and operational expertise. For instance, we have our Pipeline Operations team that will take a commercial perspective—they build out corporate verticals like HR, legal, and help develop frameworks for valuations and finance. Our R&amp;D team will help sculpt the R&amp;D strategy and experiment plan, staying in lock step with the founding scientific team to ensure successful execution. Essentially, we provide key expertise and resource centrally that each pipeline can tap into flexibly. It allows us to share best practices across the platform and deploy best resources as needed.</p><h2>As COO overseeing companies in development, what is the biggest challenge?</h2><p>If you want to create an elite organization that’s capable of achieving something spectacular in an incredibly difficult field, you have to have the right team in place, empowered and informed to make the right decisions. I am fortunate to be surrounded by some of the top minds in their respective roles, and I have to continuously assess how deeply or light-touch I need to engage. To achieve consistency in outcome, I have to customize my approach for every project, program, and team. It’s challenging and rewarding.</p><h2>Why did you choose neuroscience for your PhD?</h2><p>To me, neuroscience felt like it had the most unanswered questions. Not only is the brain itself scientifically difficult to understand, it is also complexly linked to our bodies, beliefs and philosophies, and even technological endeavors. We’re trying to answer so many questions here at cambrian as well, and what keeps me excited is bringing clarity to ambiguity, pursuing answers to difficult questions and coming up with innovative solutions. My ambition is that my work will contribute to finding some of the answers that positively impact on society and humankind.<br/></p></div></article></div></section></main><footer tabindex="0" class="footer"><div class="s overflow"><div class="c"><div class="footer-c1"><div class="abs abs-footer w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="641" height="707" viewBox="0 0 641 707" fill="none"><path d="M354.374 82.496c-35.704 0-69.787 6.971-100.963 19.628l-3.479-8.54-.464.189C147.839 135.262 76.204 235.231 76.204 351.963c0 153.916 124.54 278.689 278.17 278.689 76.64 0 146.042-31.051 196.352-81.282l.354-.354-6.523-6.504c4.175-4.183 8.215-8.503 12.11-12.953 12.109-13.835 33.326-16.657 47.005-4.508l36.661 32.572C576.491 647.715 471.516 706.5 352.84 706.5 158.249 706.5.5 548.458.5 353.5S158.249.5 352.84.5C461.497.5 558.667 49.777 623.3 127.244l-34.623 33.601c-12.802 12.425-33.477 10.972-46.279-1.568-48.493-47.502-114.844-76.781-188.024-76.781zM86.409 351.963c0-112.276 68.793-208.454 166.454-248.535l19.586 48.078c6.297 15.454-1.276 32.96-15.54 41.777-12.231 7.561-23.523 16.5-33.66 26.602l-6.55-6.563-.354.355c-35.31 35.416-57.147 84.32-57.147 138.332 0 108.102 87.471 195.74 195.376 195.74 26.256 0 51.305-5.19 74.179-14.602l.46-.189-3.461-8.541c12.978-5.392 25.211-12.212 36.51-20.263 13.595-9.688 32.522-9.881 44.272 1.843l36.607 36.515c-48.435 48.162-115.133 77.918-188.767 77.918-27.697 0-54.411-4.209-79.54-12.024-10.826-3.369-21.358-7.403-31.547-12.061C150.735 554.05 86.409 460.531 86.409 351.963zm323.26 135.452l14.779 36.45c-21.56 8.808-45.151 13.662-69.874 13.662-102.267 0-185.172-83.057-185.172-185.518a186.35 186.35 0 0 1 5.215-43.901c8.064-33.297 25.098-63.085 48.393-86.648l.198-.2 30.414 30.47c11.764 11.786 11.372 30.85 3.098 45.49-9.373 16.586-14.723 35.753-14.723 56.172 0 63.051 51.019 114.168 113.957 114.168 4.419 0 8.78-.254 13.066-.741 16.688-1.912 34.385 5.149 40.649 20.596z" stroke="url(#A)"/><defs><linearGradient id="A" x1="320.5" y1="0" x2="320.5" y2="707" gradientUnits="userSpaceOnUse"><stop stop-color="#335D2D" stop-opacity="0"/><stop offset=".255" stop-color="#109e5a"/><stop offset=".531" stop-color="#36c"/><stop offset=".771" stop-color="#d8a76e"/><stop offset="1" stop-color="#335D2D" stop-opacity="0"/></linearGradient></defs></svg></div><div tabindex="0" class="c c-260-prt"><h3 class="p-32">We want to hear from you.</h3><div tabindex="0" class="pc pc-30"><a aria-label="Contact us (opens in a new tab)" tabindex="0" href="../contact.html" target="_blank" class="btn w-button">Contact us</a></div></div></div></div></div><div class="s"><div class="c"><div class="footer-c2"><div class="left-110"><div class="flex flex-center block-prt"><a href="../index.html" aria-label="home" class="w-inline-block"><div class="w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="7.1875em" height="1.25em" viewBox="0 0 115 20" fill="currentColor"><path d="M104.144 7.712a5.74 5.74 0 0 1 3.918-1.489 6.14 6.14 0 0 1 2.638.589c.823.389 1.543.956 2.107 1.657.836 1.029 1.28 2.327 1.28 4.518v6.226h-2.641v-6.377c0-1.626-.304-2.382-.776-2.951a3.44 3.44 0 0 0-1.199-.91c-.464-.213-.971-.322-1.484-.32a4.92 4.92 0 0 0-2.083.495 4.79 4.79 0 0 0-1.657 1.327v8.736h-2.641V6.496h2.557l-.019 1.216zM36.15 6.559V7.78c1.04-.948 2.409-1.48 3.833-1.489.881-.005 1.752.182 2.549.547s1.501.898 2.06 1.562a6.54 6.54 0 0 1 2.246-1.577c.855-.364 1.781-.545 2.714-.532a6.04 6.04 0 0 1 2.569.552 5.89 5.89 0 0 1 2.068 1.584c.804.975 1.192 2.218 1.192 4.359v6.49h-2.637V12.38c0-1.303-.276-2.004-.748-2.546a3.2 3.2 0 0 0-1.098-.815c-.423-.191-.882-.291-1.347-.291a5.49 5.49 0 0 0-2.187.497 5.36 5.36 0 0 0-1.787 1.325 10.14 10.14 0 0 1 .234 2.236v6.49h-2.637V12.38c0-1.303-.28-2.004-.753-2.546-.315-.35-.703-.63-1.139-.821s-.908-.288-1.386-.286c-.709.03-1.403.209-2.035.523s-1.188.757-1.63 1.299v8.727H33.59V6.559h2.557zM9.817.001c1.33-.014 2.648.238 3.874.741a9.71 9.71 0 0 1 3.25 2.183L15.754 4.1a.95.95 0 0 1-1.225.082C13.187 3.147 11.528 2.58 9.817 2.57c-3.974 0-7.054 3.088-7.054 7.169 0 4.277 3.165 7.174 7.302 7.174 1.891-.034 3.697-.774 5.044-2.068a.95.95 0 0 1 1.257 0l1.253 1.116c-.915 1.092-2.067 1.974-3.373 2.582a10.03 10.03 0 0 1-4.181.934C4.277 19.481 0 15.341 0 9.739 0 4.277 4.207.001 9.817.001zm69.715 7.87a.85.85 0 0 1-.069.335.87.87 0 0 1-.196.283c-.084.081-.183.145-.293.188s-.227.065-.345.064a4.62 4.62 0 0 0-2.202.582 4.47 4.47 0 0 0-1.631 1.554v8.335h-2.641V6.496h2.557v1.512a4.9 4.9 0 0 1 1.774-1.254 5.02 5.02 0 0 1 2.158-.376c.297-.002.594.016.888.055v1.439zM82.421.269a1.79 1.79 0 0 1 .672.129 1.75 1.75 0 0 1 .569.37 1.7 1.7 0 0 1 .38.555 1.66 1.66 0 0 1 .132.654 1.64 1.64 0 0 1-.137.646 1.68 1.68 0 0 1-.382.545 1.73 1.73 0 0 1-.568.359 1.76 1.76 0 0 1-.666.117 1.73 1.73 0 0 1-.663-.12 1.69 1.69 0 0 1-.562-.363 1.66 1.66 0 0 1-.372-.548 1.61 1.61 0 0 1-.123-.646 1.64 1.64 0 0 1 .124-.648c.085-.206.211-.393.371-.552a1.7 1.7 0 0 1 .561-.369 1.76 1.76 0 0 1 .664-.13zm-1.304 6.226h2.641v12.717h-2.641V6.496zm-52.512.001v8.736a4.49 4.49 0 0 1-1.57 1.322c-.621.316-1.31.487-2.011.5-.569.01-1.134-.092-1.663-.298a4.27 4.27 0 0 1-1.412-.905c-.404-.391-.724-.856-.94-1.369s-.325-1.063-.319-1.618c0-2.218 1.58-4.195 3.702-4.195a3.19 3.19 0 0 1 1.575.355.96.96 0 0 0 .584.11c.202-.026.389-.116.534-.255l1.402-1.366a6.24 6.24 0 0 0-3.885-1.284c-1.12-.013-2.222.267-3.193.811-1.031.602-1.883 1.456-2.471 2.476s-.894 2.174-.885 3.344c-.013 1.164.287 2.311.872 3.327a6.74 6.74 0 0 0 2.457 2.462 6.82 6.82 0 0 0 3.272.838 6.09 6.09 0 0 0 4.03-1.435v1.166h2.552V6.496h-2.632zm67.461-.119V15.1c-.412.553-.949 1.005-1.571 1.321a4.63 4.63 0 0 1-2.01.501 4.36 4.36 0 0 1-1.663-.3 4.27 4.27 0 0 1-1.412-.906 4.15 4.15 0 0 1-.939-1.37 4.06 4.06 0 0 1-.319-1.618c0-2.218 1.585-4.195 3.707-4.195.546-.017 1.088.106 1.571.355a.96.96 0 0 0 .584.11c.202-.026.389-.116.534-.255l1.402-1.366c-1.005-.74-2.211-1.178-3.469-1.259a6.6 6.6 0 0 0-3.609.803 6.79 6.79 0 0 0-2.474 2.473c-.589 1.021-.895 2.173-.887 3.344a6.51 6.51 0 0 0 .872 3.329c.585 1.016 1.434 1.864 2.461 2.46a6.81 6.81 0 0 0 3.272.838c1.477.022 2.911-.489 4.025-1.435v1.166h2.552V6.377h-2.627zm-28.978.656c-.971-.544-2.073-.824-3.193-.811a6.15 6.15 0 0 0-3.922 1.366l1.309 1.339a.94.94 0 0 0 .53.274.96.96 0 0 0 .592-.096 3.34 3.34 0 0 1 1.543-.373c2.211 0 3.861 1.904 3.861 4.099.006.554-.103 1.104-.319 1.616s-.535.978-.938 1.369a4.27 4.27 0 0 1-1.411.905 4.36 4.36 0 0 1-1.661.3c-.702-.012-1.391-.182-2.014-.498a4.49 4.49 0 0 1-1.572-1.323V0h-2.636v19.212h2.58v-1.166c1.113.947 2.547 1.458 4.025 1.435a6.83 6.83 0 0 0 3.272-.838c1.027-.596 1.875-1.445 2.46-2.461a6.52 6.52 0 0 0 .873-3.328c.007-1.173-.301-2.328-.894-3.349a6.81 6.81 0 0 0-2.486-2.472z"/></svg></div></a><div class="copyright"><p class="p-17 regular">© 2023 cambrian® BioPharma, Inc. All rights reserved.</p></div></div></div><div class="right-110"><div class="flex flex-center block-prt"><a href="../privacy-policy.html" tabindex="0" class="link link-footer">Policies</a><a href="../news-and-publications.html" tabindex="0" rel="noopener" class="link link-footer">Press</a><div class="flex flex-justify-center"><a tabindex="0" aria-label="linkedin" rel="noopener" href="https://www.linkedin.com/company/cambrianbio/about/" target="_blank" class="link-social w-inline-block"><div class="w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="1.0625em" height="1em" viewBox="0 0 17 16" fill="#e2ecff"><path d="M16.328 15.874a61.67 61.67 0 0 0-2.93 0c-.211 0-.258-.046-.258-.255V10.44c0-.395-.023-.79-.141-1.161-.352-1.207-1.758-1.649-2.766-.836-.539.418-.75.998-.75 1.695v4.876c0 .209-.023.418 0 .65.023.186-.07.232-.234.209h-3c-.187 0-.234-.046-.234-.232l.023-4.412-.023-5.41c0-.209.047-.255.234-.255h3c.188 0 .234.046.234.232V6.98l.117-.116c.914-1.324 2.203-1.695 3.727-1.463 1.758.279 2.883 1.486 3.164 3.344.07.441.094.882.094 1.324v5.55c0 .186-.047.255-.258.255zM4.141 10.719v4.876c0 .209-.047.279-.258.279-.984-.023-1.969 0-2.953 0-.187 0-.234-.046-.234-.232V5.796c0-.163.047-.232.234-.232h3.023c.211 0 .234.07.234.255l-.047 4.9zm.164-7.849c-.234.929-1.195 1.463-2.297 1.277C.836 3.962.18 2.824.602 1.709.883 1.013 1.562.595 2.43.618 3.742.595 4.609 1.64 4.305 2.87z"/></svg></div></a><a tabindex="0" aria-label="twitter" rel="noopener" href="https://mobile.twitter.com/cambrianbio" target="_blank" class="link-social w-inline-block"><div class="w-embed"><svg xmlns="http://www.w3.org/2000/svg" width="1em" height="0.875em" viewBox="0 0 16 14" fill="none"><path d="M14.387 4.131v.415c0 4.293-3.309 9.25-9.34 9.25-1.864 0-3.581-.539-5.047-1.452.251.021.524.041.775.041 1.529 0 2.953-.518 4.084-1.39-1.445-.021-2.66-.975-3.058-2.261a3.07 3.07 0 0 0 .628.062c.293 0 .586-.041.859-.124C1.78 8.383.649 7.077.649 5.5v-.041a3.25 3.25 0 0 0 1.487.415A3.25 3.25 0 0 1 .67 3.157c0-.601.168-1.161.44-1.638 1.613 1.97 4.042 3.256 6.764 3.401-.063-.228-.084-.498-.084-.747 0-1.804 1.466-3.256 3.288-3.256.942 0 1.801.394 2.387 1.016.754-.145 1.445-.415 2.094-.788-.251.767-.775 1.39-1.445 1.804.67-.083 1.298-.249 1.885-.518-.419.664-.963 1.244-1.613 1.701z" fill="#e2ecff"/></svg></div></a></div></div></div></div></div></div></footer><script src="https://d3e54v103j8qbb.cloudfront.net/js/jquery-3.5.1.min.dc5e7f18c8.js?site=600be113c4111047016de64a" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script><script src="https://cdn.prod.website-files.com/600be113c4111047016de64a/js/webflow.0527a82382a637c47b9102f8ac6f9982.js" type="text/javascript"></script><script>
// PAGE TRANSITION
function tr(myLink) {
    return (myLink.host == window.location.host);
}
$('a:not(.w-pagination-next)').each(function() {
  if (tr(this) && (this).href.indexOf('#') === -1) {
  $(this).click(function(e){
  e.preventDefault();
  var moduleURL = jQuery(this).attr("href");
  setTimeout( function() { window.location = moduleURL }, 350 );
  $('.tr').css("opacity", "1");
});
    }
});
  $(window).bind("pageshow", function(event) {
    if (event.originalEvent.persisted) {
        window.location.reload() 
    }
});

// NAV INTERACTIONS
$('.menu-btn').click(function() {
$('.nav').toggleClass('nav-open');
});
  
// LOCK SCROLL - MENU OPEN
(function(){$(".menu-btn").click(function(){$("body").toggleClass("overflow")})}).call(this),function(){var t=document.getElementById("menu"),e=null;t.addEventListener("touchstart",function(t){1===t.targetTouches.length&&(e=t.targetTouches[0].clientY)},!1),t.addEventListener("touchmove",function(n){1===n.targetTouches.length&&function(n){var o=n.targetTouches[0].clientY-e;0===t.scrollTop&&o>0&&n.preventDefault(),t.scrollHeight-t.scrollTop<=t.clientHeight&&o<0&&n.preventDefault()}(n)},!1)}();
</script>


<script>
document.addEventListener('DOMContentLoaded', function() {
    // Select all interactive elements
    var focusableElements = 'a[href], button, input, textarea, select, details, [tabindex]:not([tabindex="-1"])';
    var focusables = document.querySelectorAll(focusableElements);

    // Add a keydown event listener to each focusable element
    focusables.forEach(function(element) {
        element.addEventListener('keydown', function(e) {
            if (e.key === 'Tab') {
                // Prevent the default tab behavior
                e.preventDefault();
                var index = Array.prototype.indexOf.call(focusables, e.target);
                var nextElement = focusables[index + (e.shiftKey ? -1 : 1)];
                if (!nextElement) {
                    nextElement = focusables[e.shiftKey ? focusables.length - 1 : 0];
                }
                nextElement.focus();
            }
        });
    });
});
</script>

<script>
// CHANGE NAV BACKGROUND ON SCROLL
$(window).scroll(function() {
    $(document).scrollTop() > 0 ? $(".s.nav").css({
        "background":"linear-gradient(20.76deg, #335D2D -1.44%, #28557D 80.56%)"
    }) : $(".nav").css({
        "background":"none"
    })
});
</script></body></html>